A sustainable balance between innovation and risk: How the “right to science” affects China’s medical biotechnology regulatory policy

Medical biotechnology is at the forefront of scientific progress, with humanity facing a critical juncture during the pandemic. However, to maximize these benefits, governments face the complex challenge of reconciling innovation and risk. A sustainable balance is critical, as extreme measures such...

Full description

Bibliographic Details

Published in:	Computational and Structural Biotechnology Journal
Main Authors:	Yiping Han, Lindsay L. Fan, Yang Xue
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Subjects:	Right to science Medical biotechnology China Regulatory policy Biosafety and biosecurity Risk and innovation
Online Access:	http://www.sciencedirect.com/science/article/pii/S2001037024001107